Related news from |
Wed, 27 Mar 2024 20:37:08 +0000 |
Corporate Insiders Are Selling These 10 Small-Cap Stocks
In this article, we will take a detailed look at Corporate Insiders Are Selling These 10 Small-Cap Stocks. For a quick overview of such stocks, read our article Corporate Insiders Are Selling These 5 Small-Cap Stocks. When the inflation crisis started and the Federal Reserve began raising interest rates, investors were quick to exit small-cap stocks which are deemed […]
|
Thu, 14 Mar 2024 06:15:04 +0000 |
Director Amy Duross Sells 11,200 Shares of BioLife Solutions Inc (BLFS)
BioLife Solutions Inc (NASDAQ:BLFS), a leading developer, manufacturer, and supplier of bioproduction tools and services for cell and gene therapies, has reported an insider sale according to a recent SEC filing.
|
Wed, 13 Mar 2024 05:50:09 +0000 |
Insider Sell: Chief Marketing Officer Todd Berard Sells 7,508 Shares of BioLife Solutions Inc (BLFS)
BioLife Solutions Inc (NASDAQ:BLFS), a leading developer, manufacturer, and supplier of bioproduction tools and services for cell and gene therapies, has reported an insider sell according to the latest SEC filings.
|
Fri, 08 Mar 2024 18:58:42 +0000 |
When Will BioLife Solutions, Inc. (NASDAQ:BLFS) Become Profitable?
BioLife Solutions, Inc. ( NASDAQ:BLFS ) is possibly approaching a major achievement in its business, so we would like...
|
Mon, 04 Mar 2024 13:03:00 +0000 |
BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced that Roderick de Greef, Chief Executive Officer, and Troy Wichterman, Chief Financial Officer, will present and meet with current and prospective investors at the following March Investor Conferences.
|
Sat, 02 Mar 2024 13:16:17 +0000 |
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ:BLFS) Q4 2024 Earnings Call Transcript February 29, 2024 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.36. BioLife Solutions, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon, ladies and […]
|
Fri, 01 Mar 2024 11:02:57 +0000 |
Q4 2023 BioLife Solutions Inc Earnings Call
Q4 2023 BioLife Solutions Inc Earnings Call
|
Thu, 29 Feb 2024 21:03:00 +0000 |
BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene therapy (CGT) and broader biopharma markets, today announced financial results for the fourth quarter and year ended December 31, 2023, and introduces 2024 revenue guidance.
|
Tue, 20 Feb 2024 13:03:00 +0000 |
BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's fourth quarter and full year 2023 financial results will be released after market close on Thursday, February 29, 2024. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and gi
|
Sat, 17 Feb 2024 12:27:45 +0000 |
Should You Think About Buying BioLife Solutions, Inc. (NASDAQ:BLFS) Now?
While BioLife Solutions, Inc. ( NASDAQ:BLFS ) might not have the largest market cap around , it saw a significant share...
|
Fri, 19 Jan 2024 10:10:28 +0000 |
Is There An Opportunity With BioLife Solutions, Inc.'s (NASDAQ:BLFS) 36% Undervaluation?
Key Insights The projected fair value for BioLife Solutions is US$26.50 based on 2 Stage Free Cash Flow to Equity...
|
Mon, 08 Jan 2024 13:15:00 +0000 |
BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue
BioLife Solutions, Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced 2023 fourth quarter and full year preliminary unaudited revenue.
|
Thu, 16 Nov 2023 10:11:46 +0000 |
Analysts Just Shaved Their BioLife Solutions, Inc. (NASDAQ:BLFS) Forecasts Dramatically
The analysts covering BioLife Solutions, Inc. ( NASDAQ:BLFS ) delivered a dose of negativity to shareholders today, by...
|
Thu, 16 Nov 2023 07:54:41 +0000 |
BioLife Solutions (BLFS) was Impacted by Inventory Destocking and Elongated Sales Cycles
Conestoga Capital Advisors, an asset management company, released its “Micro Cap Strategy” third-quarter 2023 investor letter. A copy of the same can be downloaded here. The micro capitalization segment of the market proved the most challenging in the quarter with the Russell Micro Cap Index declining -7.93%. The Russell Micro Cap Growth Index fell further with a […]
|
Fri, 10 Nov 2023 19:33:47 +0000 |
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript
BioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38. Operator: Good afternoon, ladies and gentlemen, and thank you for standing by. Welcome to the BioLife Solutions Third Quarter 2023 Shareholder and Analyst Conference Call. At this time, all participants […]
|
Thu, 09 Nov 2023 21:04:00 +0000 |
BioLife Solutions Reports Third Quarter 2023 Financial Results
BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading supplier of biopreservation media and other cell processing tools and biostorage services for the cell and gene therapy (CGT) and broader biopharma markets, today announced financial results for the third quarter and nine months of 2023.
|
Thu, 02 Nov 2023 20:03:00 +0000 |
BioLife Solutions to Provide Third Quarter 2023 Financial Results and Business Update on November 9, 2023
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader biopharma markets, today announced the Company's third quarter financial results will be released after market close on Thursday, November 9, 2023. The Company will host a conference call and live webcast at 4:30pm ET (1:30pm PT) that day. Management will provide an overview of the Company's financial results and a general business upda
|
Thu, 02 Nov 2023 04:27:27 +0000 |
Former CEO Michael Rice Sells 72,603 Shares of BioLife Solutions Inc
On October 30, 2023, former CEO and Director Michael Rice sold 72,603 shares of BioLife Solutions Inc (NASDAQ:BLFS).
|
Thu, 19 Oct 2023 21:04:00 +0000 |
BioLife Solutions Announces Leadership Transitions & Preliminary Third Quarter Revenue with Updated Outlook for 2023
BioLife Solutions, Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma markets, today announced Roderick de Greef has been appointed as Chairman of the Board of Directors and Chief Executive Officer replacing Michael Rice who is retiring after a seventeen year tenure, effective immediately. Rice has agreed to consult for the Company until March 31, 2024, to support a smooth transition.
|
Mon, 09 Oct 2023 08:24:00 +0000 |
New Strong Sell Stocks for October 9th
BLFS, BWMN and FTEK have been added to the Zacks Rank #5 (Strong Sell) List on October 9, 2023.
|